Effective Targeting of TAG72(+) Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells

Impressive clinical efficacy of chimeric antigen receptor (CAR)-engineered T cell therapy for hematological malignancies have prompted significant efforts in achieving similar responses in solid tumors. The lack of truly restricted and uniform expression of tumor-associated antigens, as well as limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Murad, John P., Kozlowska, Anna K., Lee, Hee Jun, Ramamurthy, Maya, Chang, Wen-Chung, Yazaki, Paul, Colcher, David, Shively, John, Cristea, Mihaela, Forman, Stephen J., Priceman, Saul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254427/
https://www.ncbi.nlm.nih.gov/pubmed/30510550
http://dx.doi.org/10.3389/fimmu.2018.02268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254427/
https://www.ncbi.nlm.nih.gov/pubmed/30510550
http://dx.doi.org/10.3389/fimmu.2018.02268

Ejemplares similares